Clinical significance of the physicochemical properties of LDL in type 2 diabetes
Authors:
- 14 April 2005
- journal article
- review article
- Published by Springer Nature in Diabetologia
- Vol. 48 (5) , 808-816
Abstract
Atherosclerosis is the leading cause of death in type 2 diabetes. LDL cholesterol and atherosclerosis are related, both in healthy people and those with diabetes; however, people with diabetes are more prone to atheroma, even though their LDL cholesterol levels are similar to those in their non-diabetic peers. This is because LDL particles are modified in the presence of diabetes to become more atherogenic. These modifications include glycation in response to high plasma glucose levels; oxidative reactions mediated by increased oxidative stress; and transfer of cholesterol ester, which makes the particles smaller and denser. The latter modification is strongly associated with hypertriglyceridaemia. Oxidatively and non-oxidatively modified LDL is involved in plaque formation, and may thus contribute to the accelerated atherosclerosis. This review discusses the techniques currently used to determine the physicochemical properties of LDL, and examines the evidence that modification of these properties plays a role in the accelerated atherosclerosis associated with type 2 diabetes.Keywords
This publication has 87 references indexed in Scilit:
- LDL oxidative modifications in well- or moderately controlled type 2 diabetesDiabetes/Metabolism Research and Reviews, 2004
- Comparison of the Associations of Apolipoprotein B and Low-Density Lipoprotein Cholesterol With Other Cardiovascular Risk Factors in the Insulin Resistance Atherosclerosis Study (IRAS)Circulation, 2003
- Immunoglobulin M Type of Autoantibodies to Oxidized Low-Density Lipoprotein Has an Inverse Relation to Carotid Artery AtherosclerosisCirculation, 2003
- Obesity and Systemic Oxidative StressArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- LDL-cholesterol/apolipoprotein B ratio is a good predictor of LDL phenotype B in type 2 diabetesActa Diabetologica, 2002
- Low-Density Lipoprotein Particle Concentration and Size as Determined by Nuclear Magnetic Resonance Spectroscopy as Predictors of Cardiovascular Disease in WomenCirculation, 2002
- Relationship of Oxidative Stress and Fibrinolysis in Diabetes MellitusDiabetic Medicine, 1996
- Influence of plasma lipid and LDL-subfraction profile on the interaction between low density lipoprotein with human arterial wall proteoglycansAtherosclerosis, 1996
- Effect of Diabetes on Lipoprotein SizeArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Pathophysiological concentrations of glucose promote oxidative modification of low density lipoprotein by a superoxide-dependent pathway.Journal of Clinical Investigation, 1994